XBiotech Inc.
XBIT
$2.92
-$0.06-2.01%
NASDAQ
| 06/30/2025 | 03/31/2025 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -- | -- | |||
| SG&A Expenses | -48.21% | 108.31% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -53.24% | 54.89% | |||
| Operating Income | 53.24% | -54.89% | |||
| Income Before Tax | 84.08% | -2.90% | |||
| Income Tax Expenses | -3.45% | 170.73% | |||
| Earnings from Continuing Operations | 83.87% | -3.58% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 83.87% | -3.58% | |||
| EBIT | 53.24% | -54.89% | |||
| EBITDA | 55.01% | -57.76% | |||
| EPS Basic | 83.87% | -3.51% | |||
| Normalized Basic EPS | 84.09% | -2.82% | |||
| EPS Diluted | 83.87% | -3.51% | |||
| Normalized Diluted EPS | 84.09% | -2.82% | |||
| Average Basic Shares Outstanding | 0.00% | 0.07% | |||
| Average Diluted Shares Outstanding | 0.00% | 0.07% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||